A Guide to Periprocedural Skin Care Regimen for Injectable and Nonenergy Cosmetic Procedures Based on a Consensus of 6 Aesthetic Practitioners

基于6位美容从业者共识的注射和非能量美容手术围手术期皮肤护理方案指南

阅读:1

Abstract

The use of injectable aesthetic treatments (including fillers, neurotoxins, polynucleotides, and biostimulators) and nonenergy surface-active aesthetic treatments (such as chemical peels, microneedling, and microdermabrasion) is increasing. To date, little guidance is available in the literature concerning periprocedural skincare for these aesthetic procedures. The aim of the authors of this study is to provide periprocedural skincare recommendations and an algorithm to guide holistic skincare that will enhance and retain procedural effects and optimize skin health in the longer term. A panel of 6 Australian aesthetic practitioners (5 dermatologists and 1 plastic surgeon) developed generalized periprocedural skincare recommendations for injectable and surface-active aesthetic treatments. Recommendations were stratified into 2 categories: skin barrier nondisruptive procedures (fillers, threads, neuromodulators, and polynucleotides) and skin barrier disruptive procedures (nonenergy surface-active procedures). Establishing a good preprocedural basic skincare routine (cleanser, moisturizer, and broad-spectrum sun protection factor 50+ sunscreen) 2 to 4 weeks before a procedure is recommended. Actives including vitamin A, vitamin B3, antioxidants, hyaluronic acid, and lipids may also be advised and tailored to an individual's skin condition. It is suggested that toners and exfoliants can be avoided, whereas antioxidants, tranexamic acid, and growth factors can be used immediately following needling procedures. Hyaluronic acid and antioxidants may be used immediately following chemical peels along with bland skincare. Postprocedural makeup and skincare actives should be avoided immediately post surface-active procedures. The implementation of periprocedural skincare regimens may improve treatment-related outcomes and reduce recovery time. Furthermore, frequency and severity of potential side effects may be reduced. Level of Evidence: 5 (Therapeutic).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。